Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414086 · ClinicalTrials.gov registry record
Predictor of Clinical Response to Acthar in Myositis
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 20
- Enrollment target
NCT03414086 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 20 participants.
The verdict
NCT03414086 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Comparing the clinical effects of Acthar Gel before and after treatment and compare it to patients with inactive disease.
Interventions
- OTHER Healthy Control
- OTHER Myositis in Remission
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2022-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03414086
The ClinicalTrials.gov registry entry for NCT03414086 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Healthy Control is the first listed.
NCT03414086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03414086 about?
NCT03414086 is a clinical study titled "Predictor of Clinical Response to Acthar in Myositis". Comparing the clinical effects of Acthar Gel before and after treatment and compare it to patients with inactive disease.
What is the current status of trial NCT03414086?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2017-11-06. Estimated completion is 2022-07-30.
What interventions are being tested in trial NCT03414086?
The interventions under investigation include: Healthy Control (OTHER), Myositis in Remission (OTHER).
Who is sponsoring clinical trial NCT03414086?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.